Drug Delivery
Volume 25, 2018 - Issue 1
Open access
2,895
Views
52
CrossRef citations to date
0
Altmetric
Research Article
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee KimDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Ji Eun WonDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Yeongseon ByeonDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Min Gi KimDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Tae In WiDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Jae Myeong LeeDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Yun-Yong ParkAsan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; ;Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea; View further author information
, Jeong-Won LeeDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; View further author information
, Tae Heung KangDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea;
http://orcid.org/0000-0002-9853-913XView further author information
In Duk JungDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; View further author information
, Byung Cheol ShinBio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; View further author information
, Hyung Jun AhnCenter for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Republic of Korea; View further author information
, Young Joo LeeDepartment of Bioscience and Biotechnology, Sejong University, Kwang-Jin-Gu, Seoul, Republic of Korea; View further author information
, Anil K. SoodDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; ;Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; ;Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
, View further author information
Hee Dong HanDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; Correspondence[email protected]
http://orcid.org/0000-0002-3300-5575View further author information
Yeong-Min ParkDepartment of Immunology School of Medicine, Konkuk University, Chungju, South Korea; Correspondence[email protected]
View further author information
show allView further author information
Pages 1394-1402
|
Received 31 Jan 2018, Accepted 21 May 2018, Published online: 11 Jun 2018
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.